Congress 116 - HR 7839 - Continuing Access to In-Home IVIG Act

Sponsor

Cosponsors

Topics

Congressional oversight Drug therapy Government studies and investigations Health Health programs administration and funding Health technology, devices, supplies Hereditary and development disorders Home and outpatient care Immunology and vaccination Medicare

Full Text

View Full Bill Text

Votes

Summary

Continuing Access to In-Home IVIG Act

This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.

Actions

Jul 29, 2020

Referred to the Subcommittee on Health.
Jul 29, 2020

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 29, 2020

Introduced in House

Amendments

Related Bills